These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 21426124)

  • 1. 4th Anglo-Swedish Medicinal Chemistry Symposium.
    Hall A
    Future Med Chem; 2009 Jun; 1(3):431-4. PubMed ID: 21426124
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Medicinal chemistry--first Anglo-Swedish symposium. 23-26 March, 2003, Are Fjällby, Sweden.
    Lauret C
    IDrugs; 2003 May; 6(5):426-8. PubMed ID: 12841203
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Medicinal Chemistry - XXth International Symposium.
    Watt J; Sutton G
    IDrugs; 2008 Nov; 11(11):771-3. PubMed ID: 18988115
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anglo-Swedish Medicinal Chemistry - second symposium.
    Sarabu R
    IDrugs; 2005 May; 8(5):384-6. PubMed ID: 15883916
    [No Abstract]   [Full Text] [Related]  

  • 5. [Mechanism of action of HMG-CoA reductase inhibitors. Medical-chemical aspects of statins].
    Stark H
    Pharm Unserer Zeit; 2003; 32(6):464-71. PubMed ID: 14639827
    [No Abstract]   [Full Text] [Related]  

  • 6. Recombinant Schistosoma mansoni 3-hydroxymethylglutaryl-coenzyme-A reductase has different inhibitor kinetics compared to the mammalian host enzyme.
    El-Meanawy A; Hammd H; Chen GZ; Rottman F; Bennett JL
    Trop Gastroenterol; 2005; 26(3):132-5. PubMed ID: 16512462
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structural mechanism for statin inhibition of HMG-CoA reductase.
    Istvan ES; Deisenhofer J
    Science; 2001 May; 292(5519):1160-4. PubMed ID: 11349148
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Heat-Shock Protein 90-Targeted Nano Anticancer Therapy.
    Rochani AK; Ravindran Girija A; Borah A; Maekawa T; Sakthi Kumar D
    J Pharm Sci; 2016 Apr; 105(4):1454-66. PubMed ID: 26886301
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Proteopedia entry: HMG-CoA reductase.
    Canner D
    Biochem Mol Biol Educ; 2011; 39(1):64. PubMed ID: 21433257
    [No Abstract]   [Full Text] [Related]  

  • 10. Allosteric inhibitors of HMG-CoA reductase, the key enzyme involved in cholesterol biosynthesis.
    Haber A; Abu-Younis Ali A; Aviram M; Gross Z
    Chem Commun (Camb); 2013 Dec; 49(93):10917-9. PubMed ID: 23958894
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Venomics in medicinal chemistry.
    Dutertre S
    Future Med Chem; 2014 Oct; 6(15):1609-10. PubMed ID: 25406000
    [No Abstract]   [Full Text] [Related]  

  • 12. Discovery and quantitative structure-activity relationship study of lepidopteran HMG-CoA reductase inhibitors as selective insecticides.
    Zang YY; Li YM; Yin Y; Chen SS; Kai ZP
    Pest Manag Sci; 2017 Sep; 73(9):1944-1952. PubMed ID: 28247468
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structural mechanism for statin inhibition of 3-hydroxy-3-methylglutaryl coenzyme A reductase.
    Istvan ES
    Am Heart J; 2002 Dec; 144(6 Suppl):S27-32. PubMed ID: 12486413
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Design and synthesis of dual-action inhibitors targeting histone deacetylases and 3-hydroxy-3-methylglutaryl coenzyme A reductase for cancer treatment.
    Chen JB; Chern TR; Wei TT; Chen CC; Lin JH; Fang JM
    J Med Chem; 2013 May; 56(9):3645-55. PubMed ID: 23570542
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Discovery of a new class of HMG-CoA reductase inhibitor from Polyalthia longifolia as potential lipid lowering agent.
    Sashidhara KV; Singh SP; Srivastava A; Puri A; Chhonker YS; Bhatta RS; Shah P; Siddiqi MI
    Eur J Med Chem; 2011 Oct; 46(10):5206-11. PubMed ID: 21872367
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Medicinal Chemistry - XXth International Symposium. Lead finding strategies and kinase selectivity.
    Rotella DP
    IDrugs; 2008 Nov; 11(11):774-8. PubMed ID: 18988116
    [No Abstract]   [Full Text] [Related]  

  • 17. Exploration of natural product ingredients as inhibitors of human HMG-CoA reductase through structure-based virtual screening.
    Lin SH; Huang KJ; Weng CF; Shiuan D
    Drug Des Devel Ther; 2015; 9():3313-24. PubMed ID: 26170618
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High throughput discovery of heteroaromatic-modifying enzymes allows enhancement of novobiocin selectivity.
    Patel SM; de la Fuente M; Ke S; Guimarães AM; Oliyide AO; Ji X; Stapleton P; Osbourn A; Pan Y; Bowles DJ; Davis BG; Schatzlein A; Yang M
    Chem Commun (Camb); 2011 Oct; 47(38):10569-71. PubMed ID: 21863200
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Three-dimensional quantitative structure (3-D QSAR) activity relationship studies on imidazolyl and N-pyrrolyl heptenoates as 3-hydroxy-3-methylglutaryl-CoA reductase (HMGR) inhibitors by comparative molecular similarity indices analysis (CoMSIA).
    Thilagavathi R; Kumar R; Aparna V; Sobhia ME; Gopalakrishnan B; Chakraborti AK
    Bioorg Med Chem Lett; 2005 Feb; 15(4):1027-32. PubMed ID: 15686906
    [TBL] [Abstract][Full Text] [Related]  

  • 20. mTOR inhibition potentiates HSP90 inhibitor activity via cessation of HSP synthesis.
    Acquaviva J; He S; Sang J; Smith DL; Sequeira M; Zhang C; Bates RC; Proia DA
    Mol Cancer Res; 2014 May; 12(5):703-13. PubMed ID: 24554781
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.